Long-term efficacy, tolerability and retention rate of azathioprine in 103 aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder patients: a multicentre retrospective observational study from the UK.
BACKGROUND: Azathioprine (AZA) is a common immunosuppressive drug used for relapse prevention in neuromyelitis optica (NMO). OBJECTIVES: The objective of this paper is to assess efficacy, tolerability and retention of AZA in a large NMO cohort. METHODS: We conducted a retrospective review of medical...
Principais autores: | Elsone, L, Kitley, J, Luppe, S, Lythgoe, D, Mutch, K, Jacob, S, Brown, R, Moss, K, McNeillis, B, Goh, Y, Leite, M, Robertson, N, Palace, J, Jacob, A |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
SAGE Publications
2014
|
Registros relacionados
-
Long term efficacy, adherence and reasons for discontinuation in 103 cases of neuromyelitis optica treated with azathioprine: a multicentre study from the United Kingdom
por: Elsone, L, et al.
Publicado em: (2013) -
Is azathioprine effective in highly-active neuromyelitis optica? A multicentre study from the United Kingdom
por: Elsone, L, et al.
Publicado em: (2013) -
TREATMENT OF NEUROMYELITIS OPTICA WITH AZATHIOPRINE
por: Elsone, L, et al.
Publicado em: (2012) -
METHOTREXATE MAY BE AN ALTERNATIVE TO AZATHIOPRINE IN NEUROMYELITIS OPTICA WITH AQUAPORIN-4 ANTIBODIES
por: Kitley, J, et al.
Publicado em: (2012) -
Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies
por: Kitley, J, et al.
Publicado em: (2013)